Michael Mendelsohn - Net Worth and Insider Trading

Michael Mendelsohn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Mendelsohn owns 3 companies in total, including Foghorn Therapeutics Inc (FHTX) , Cyclerion Therapeutics Inc (CYCN) , and Regado Biosciences Inc (RGDO) .

Click here to see the complete history of Michael Mendelsohn’s form 4 insider trades.

Insider Ownership Summary of Michael Mendelsohn

Ticker	Comapny	Transaction Date	Type of Owner
FHTX	Foghorn Therapeutics Inc	2020-10-22	director
CYCN	Cyclerion Therapeutics Inc	2021-06-24	director
RGDO	Regado Biosciences Inc	2015-01-01	director

Michael Mendelsohn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Mendelsohn Ownership Network

Ownership Network List of Michael Mendelsohn

No Data

Ownership Network Relation of Michael Mendelsohn

Michael Mendelsohn Owned Company Details

What does Foghorn Therapeutics Inc do?

Who are the key executives at Foghorn Therapeutics Inc?

Michael Mendelsohn is the director of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief Strategy/Bus Ops Officer Fanny Cavalie , Chief Medical Officer Alfonso Quintas Cardama , and Chief Medical Officer Samuel Agresta .

Foghorn Therapeutics Inc (FHTX) Insider Trades Summary

Over the past 18 months, Michael Mendelsohn made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 311,297 shares made by Samuel Agresta , and a net sale of 11,000 shares made by Fanny Cavalie .

In summary, during the past 3 months, insiders sold 11,000 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 11,000 shares. During the past 18 months, 322,297 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,297 shares.

Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Foghorn Therapeutics Inc Insider Transactions

No Available Data

What does Cyclerion Therapeutics Inc do?

Who are the key executives at Cyclerion Therapeutics Inc?

Michael Mendelsohn is the director of Cyclerion Therapeutics Inc. Other key executives at Cyclerion Therapeutics Inc include Chief Scientific Officer Andreas Busch , director & Chief Executive Officer Peter M Hecht , and 10 percent owner Slate Path Capital Lp .

Cyclerion Therapeutics Inc (CYCN) Insider Trades Summary

Over the past 18 months, Michael Mendelsohn made no insider transaction in Cyclerion Therapeutics Inc (CYCN). Other recent insider transactions involving Cyclerion Therapeutics Inc (CYCN) include a net sale of 8 shares made by Terrance Mcguire ,

In summary, during the past 3 months, insiders sold 0 shares of Cyclerion Therapeutics Inc (CYCN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8 shares of Cyclerion Therapeutics Inc (CYCN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8 shares.

Cyclerion Therapeutics Inc (CYCN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cyclerion Therapeutics Inc Insider Transactions

No Available Data

What does Regado Biosciences Inc do?

Who are the key executives at Regado Biosciences Inc?

Michael Mendelsohn is the director of Regado Biosciences Inc. Other key executives at Regado Biosciences Inc include 10 percent owner Associates Domain , Chief Medical Officer Eric Lefebvre , and Chief Financial Officer Christopher Peetz .

Regado Biosciences Inc (RGDO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Regado Biosciences Inc (RGDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regado Biosciences Inc (RGDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regado Biosciences Inc (RGDO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regado Biosciences Inc Insider Transactions

No Available Data

Michael Mendelsohn Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Mendelsohn. You might contact Michael Mendelsohn via mailing address: C/o Cyclerion Therapeutics, Inc., 301 Binney Street, Cambridge Ma 02142.

Discussions on Michael Mendelsohn

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.